WHY: New York, New York – 
Law Firm, a global investor rights law firm, reminds purchasers of the
securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTCMKTS: INSD; MZKR)
between December 8, 2020 and November 24, 2021, inclusive (the “Class
Period”), of the important February 28, 2022 lead plaintiff deadline.
the Class Period you may be entitled to compensation without payment of any out
of pocket fees or costs through a contingency fee arrangement.
WHAT TO
DO NEXT: To join
the Instadose class action, go to http://www.rosenlegal.com/cases-register-2217.html
or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on
the class action. A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than February 28,
2022. A lead plaintiff is a representative party acting on behalf of other
class members in directing the litigation.
WHY
ROSEN LAW: We encourage investors to select
qualified counsel with a track record of success in leadership roles. Often,
firms issuing notices do not have comparable experience, resources or any
meaningful peer recognition. Many of these firms do not actually litigate
securities class actions. Be wise in selecting counsel. The Rosen Law Firm
represents investors throughout the globe, concentrating its practice in
securities class actions and shareholder derivative litigation. Rosen Law Firm
has achieved the largest ever securities class action settlement against a
Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action
Services for number of securities class action settlements in 2017. The firm
has been ranked in the top 4 each year since 2013 and has recovered hundreds of
millions of dollars for investors. In 2019 alone the firm secured over $438
million for investors. In 2020, founding partner Laurence Rosen was named by
law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been
recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the
lawsuit, defendants throughout the Class Period made false and/or misleading
statements and/or failed to disclose that: (1) Instadose had performed
inadequate due diligence into the Business Combination and/or ignored
significant red flags associated with Instadose Canada; (2) Instadose’s
internal controls and policies were inadequate to detect and/or prevent
impermissible trading activity by control persons of the Company; (3) the
foregoing subjected Instadose to a heightened risk of regulatory scrutiny and
enforcement action; and (4) as a result, defendants’ public statements were
materially false and misleading at all relevant times. When the true
details entered the market, the lawsuit claims that investors suffered damages.
To join the Instadose class action, go to http://www.rosenlegal.com/cases-register-2217.html
or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on
the class action.
No Class Has Been
Certified. Until a class is certified, you are not represented by counsel
unless you retain one. You may select counsel of your choice. You may also
remain an absent class member and do nothing at this point. An investor’s
ability to share in any potential future recovery is not dependent upon serving
as lead plaintiff.
Follow us for updates on
LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm,
on Twitter: https://twitter.com/rosen_firm
or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior
results do not guarantee a similar outcome.
——————————-
Contact
Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View the original release on www.newmediawire.com